SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-287347
Filing Date
2017-09-18
Accepted
2017-09-18 16:26:57
Documents
2
Group Members
AMIR NASHATBRIAN CHEEBRYCE YOUNGRENDAVID BARRETTJONATHAN A. FLINTPOLARIS VENTURE FOUNDERS' FUND VI, L.P.POLARIS VENTURE MANAGEMENT CO. VI, L.L.C.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d458504dsc13da.htm SC 13D/A 149673
2 EX-99.A d458504dex99a.htm EX-99.A 10551
  Complete submission text file 0001193125-17-287347.txt   161992
Mailing Address ONE MARINA PARK DRIVE, 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE, 10TH FLOOR BOSTON MA 02210 781-290-0770
Polaris Venture Partners VI, L.P. (Filed by) CIK: 0001493463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Subject) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89319 | Film No.: 171090137
SIC: 2836 Biological Products, (No Diagnostic Substances)